Blog
RSS FeedPosted by Michael Wonder on 18 Dec 2020
Recommendations made by the PBAC - November 2020
18 December 2020 - The recommendations from the November 2020 PBAC meeting are now available. ...
Posted by Michael Wonder on 29 Nov 2020
PBS support for Australians living with leukaemia
28 November 2020 - Patients living with one of Australia’s most common forms of leukaemia are set to benefit from expanded ...
Posted by Michael Wonder on 18 Oct 2020
PBAC recommends Zeposia for patients with relapsing-remitting multiple sclerosis
16 October 2020 - Did Celgene really request its use for the treatment of non-premenopausal patients with hormone receptor positive, ...
Posted by Michael Wonder on 16 Oct 2020
Recommendations made by the PBAC - September 2020 intracycle meeting and out of session between July 2020 and September 2020 meetings
16 October 2020 - The recommendations from the September 2020 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 25 Aug 2020
Insights from the July 2020 PBAC meeting - Insights #4 (outcomes)
25 August 2020 - More insights extracted by the MAESTrO Team from the outcomes from the July 2020 PBAC meeting. ...
Posted by Michael Wonder on 24 Aug 2020
Insights from the July 2020 PBAC meeting - Insight #3 (outcomes)
25 August 2020 - Some outcomes are not clear. ...
Posted by Michael Wonder on 17 Jul 2020
Public Summary Documents - March 2020 meeting
17 July 2020 - The Public Summary Documents (first time rejections and deferrals) from the March 2020 PBAC meeting are now ...
Posted by Michael Wonder on 16 Jul 2020
Mallinckrodt and Terumo BCT announce positive recommendations for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos CE
13 July 2020 - In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement ...
Posted by Michael Wonder on 19 Jun 2020
Recommendations made by the PBAC – May 2020 intracycle meeting
19 June 2020 - There is actually only one recommendation. ...
Posted by Michael Wonder on 27 Apr 2020
Insights from the March 2020 PBAC meeting - Dupilumab (Dupixent)
27 April 2020 - Did the PBAC give Sanofi the run around? ...
Posted by Michael Wonder on 27 Apr 2020
Insights from the March 2020 PBAC meeting - Semaglutide (Ozempic)
28 April 2020 - Has Novo Nordisk shot itself in the foot? ...
Posted by Michael Wonder on 24 Apr 2020
Recommendations made by the PBAC - March 2020
24 April 2020 - The recommendations from the March 2020 PBAC meeting are now available. ...
Posted by Michael Wonder on 26 Mar 2020
Public Summary Documents - November 2019 PBAC meeting (supplement)
26 March 2020 - Additional insights from the second round of public summary documents (first time rejections and deferrals). ...
Posted by Michael Wonder on 25 Mar 2020
Public Summary Documents - November 2019 PBAC meeting
25 March 2020 - Insights from the second round of public summary documents (first time rejections and deferrals). ...
Posted by Michael Wonder on 13 Feb 2020
Recommendations made by the PBAC – December 2019 intracycle meeting
13 February 2020 - The outcomes from the December 2019 PBAC intracycle meeting are now available. ...